Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

I. F. Tannock; G. Bouche; D. A. Goldstein; Y. Goto; A. S. Lichter; K. Prabhash; P. Ranganathan; L. B. Saltz; G. S. Sonke; G. W. Strohbehn; R. von Moos; M. J. Ratain

doi:10.1016/j.annonc.2023.05.006

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

I. F. Tannock, G. Bouche, D. A. Goldstein, Y. Goto, A. S. Lichter, K. Prabhash, P. Ranganathan, L. B. Saltz, G. S. Sonke, G. W. Strohbehn, R. von Moos, M. J. Ratain

Oncology

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Pages (from-to)	638-644
Number of pages	7
Journal	Annals of Oncology
Volume	34
Issue number	8
DOIs	https://doi.org/10.1016/j.annonc.2023.05.006
State	Published - Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2023.05.006

Cite this

Tannock, I. F., Bouche, G., Goldstein, D. A., Goto, Y., Lichter, A. S., Prabhash, K., Ranganathan, P., Saltz, L. B., Sonke, G. S., Strohbehn, G. W., von Moos, R., & Ratain, M. J. (2023). Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy. Annals of Oncology, 34(8), 638-644. https://doi.org/10.1016/j.annonc.2023.05.006

@article{65b71a3d25f148a39540a040ba6dffb7,

title = "Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy",

author = "Tannock, {I. F.} and G. Bouche and Goldstein, {D. A.} and Y. Goto and Lichter, {A. S.} and K. Prabhash and P. Ranganathan and Saltz, {L. B.} and Sonke, {G. S.} and Strohbehn, {G. W.} and {von Moos}, R. and Ratain, {M. J.}",

year = "2023",

month = aug,

doi = "10.1016/j.annonc.2023.05.006",

language = "אנגלית",

volume = "34",

pages = "638--644",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "8",

}

Tannock, IF, Bouche, G, Goldstein, DA, Goto, Y, Lichter, AS, Prabhash, K, Ranganathan, P, Saltz, LB, Sonke, GS, Strohbehn, GW, von Moos, R & Ratain, MJ 2023, 'Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy', Annals of Oncology, vol. 34, no. 8, pp. 638-644. https://doi.org/10.1016/j.annonc.2023.05.006

TY - JOUR

T1 - Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

AU - Tannock, I. F.

AU - Bouche, G.

AU - Goldstein, D. A.

AU - Goto, Y.

AU - Lichter, A. S.

AU - Prabhash, K.

AU - Ranganathan, P.

AU - Saltz, L. B.

AU - Sonke, G. S.

AU - Strohbehn, G. W.

AU - von Moos, R.

AU - Ratain, M. J.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85164263846&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2023.05.006

DO - 10.1016/j.annonc.2023.05.006

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 37230253

AN - SCOPUS:85164263846

SN - 0923-7534

VL - 34

SP - 638

EP - 644

JO - Annals of Oncology

JF - Annals of Oncology

IS - 8

ER -

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

UN SDGs

Access to Document

Other files and links

Cite this